ADCN.F Stock Overview
Operates medical laboratories in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Adicon Holdings Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$1.48 |
| 52 Week High | HK$1.60 |
| 52 Week Low | HK$1.48 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | -5.53% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -1.39% |
Recent News & Updates
Recent updates
Shareholder Returns
| ADCN.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -0.9% | 0.5% |
| 1Y | n/a | 2.7% | 23.9% |
Return vs Industry: Insufficient data to determine how ADCN.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how ADCN.F performed against the US Market.
Price Volatility
| ADCN.F volatility | |
|---|---|
| ADCN.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: ADCN.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine ADCN.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 5,713 | Song Gao | www.adicon.com.cn |
Adicon Holdings Limited operates medical laboratories in the People’s Republic of China. The company offers medical testing, clinical trials, scientific research services, health management, and pathological consultation services. It is also involved in the trading of medical testing equipment.
Adicon Holdings Limited Fundamentals Summary
| ADCN.F fundamental statistics | |
|---|---|
| Market cap | US$783.18m |
| Earnings (TTM) | US$32.45m |
| Revenue (TTM) | US$455.56m |
23.6x
P/E Ratio1.7x
P/S RatioIs ADCN.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ADCN.F income statement (TTM) | |
|---|---|
| Revenue | CN¥3.30b |
| Cost of Revenue | CN¥1.88b |
| Gross Profit | CN¥1.42b |
| Other Expenses | CN¥1.18b |
| Earnings | CN¥234.89m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 43.00% |
| Net Profit Margin | 7.12% |
| Debt/Equity Ratio | 48.5% |
How did ADCN.F perform over the long term?
See historical performance and comparison